Search Results 191-200 of 1445 for 구글찌라시 を 17241833 を텔@adtopkingををSEO마케팅ををを텔@adtopkingををを구글키워드ををを
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
EPCAM. MLH1. MSH2. MSH6. STK11. PMS2. For participants with monogenic risk, the GIRA report recommends referral to a genetic counselor.
Mocetinostat is an orally administered histone deacetylase (HDAC) inhibitor. Azacitidine is a hypomethylating agent (HMA) used to treat MDS. In this study, ...
This is a Phase 2, uncontrolled, three-stage, ascending-dose-escalation study in subjects with one of three forms of TMA: atypical hemolytic uremic syndrome ( ...
Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 72 weeks of open-label treatment to evaluate ...
The Mayo Clinic Kern Center for the Science of Health Care Delivery's multidisciplinary faculty guides research on the delivery of evidence-based, ...
The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...
Dose escalation study to determine the maximum tolerated dose of NEOD001 in approximately 30 subjects with AL amyloidosis. Expansion phase to evaluate safety, ...
The purpose of this study is to conduct a telephone survey to evaluate driving difficulties that people with homonymous field loss experience in their day-to- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each year.